Figure 6
Plasma PDGF is positively correlated with VEGF levels in patients with progressive disease requiring therapy, late Rai stage, ZAP-70, and CD38 positive CLL patients. (A-D) In CLL patients with progressive disease requiring therapy (r = 0.82, P = .003), Rai stage II-IV (r = 0.88, P < .001), CD38 positive patients (r = 0.81, P = .02), and ZAP-70 positive patients (r = 0.52, P = .06), plasma PDGF strongly associated with VEGF levels. Linear regression analysis of PDGF versus VEGF levels was represented by the line in each dot plot.

Plasma PDGF is positively correlated with VEGF levels in patients with progressive disease requiring therapy, late Rai stage, ZAP-70, and CD38 positive CLL patients. (A-D) In CLL patients with progressive disease requiring therapy (r = 0.82, P = .003), Rai stage II-IV (r = 0.88, P < .001), CD38 positive patients (r = 0.81, P = .02), and ZAP-70 positive patients (r = 0.52, P = .06), plasma PDGF strongly associated with VEGF levels. Linear regression analysis of PDGF versus VEGF levels was represented by the line in each dot plot.

Close Modal

or Create an Account

Close Modal
Close Modal